SUBSCRIBE
SUBSCRIBE

Australia

Temperature-Dependent Drug May Prevent Blood Clots During Therapeutic Hypothermia, Baker IDI Heart & Diabetes Institute Study
April 13, 2010
 · 
1 min read
Gene Bandage Rejuvenates Wasted Muscle, University of Western Australia Study
April 7, 2010
 · 
1 min read
Brain Estrogen Shows Promise as Schizophrenia Treatment, Monash University Study
March 31, 2010
 · 
1 min read
Bionic Vision Australia Puts Bionic Eye In Sight
March 30, 2010
 · 
1 min read
Compound Screening for Drug Development Made Simpler, Through New Process At Walter and Eliza Hall Institute of Medical Research
March 30, 2010
 · 
1 min read
Research Store
Biotech Bay
Cardiovascular Market: Slow Growth In Cardiovascular Disease Will Be Offset By Prospects In Diabetes
March 29, 2010
 · 
3 min read
A Natural Fruit Compound May Help Asthma, New Zealand Institute for Plant and Food Research Research
March 26, 2010
 · 
1 min read
Research Store
BioMidwest
Datamonitor Report: US Healthcare Reform: A Double-Edged Sword
March 25, 2010
 · 
4 min read
New Technique Reduces Tobacco Smoke Damage to Lungs in Mice, University of Melbourne Study
March 19, 2010
 · 
1 min read
Discovery of ‘Fat’ Taste Could Hold the Key to Reducing Obesity, Deakin University Study
March 11, 2010
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Telix to Participate in Oppenheimer and TD Cowen Conferences
February 20, 2026
 · 
5 min read
Press Releases
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
February 19, 2026
 · 
16 min read
Press Releases
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
February 18, 2026
 · 
9 min read
Press Releases
Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein (“s-KL”) Isoform of the Human Klotho Gene Sequence
February 18, 2026
 · 
4 min read
Press Releases
Icon Group Deploys ChartCheck Adaptive Across Australia as Radformation Secures USFDA 510(k) Clearance
February 18, 2026
 · 
4 min read
Press Releases
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging
February 18, 2026
 · 
10 min read
Press Releases
Australian Breast Cancer Innovators Close $27M Private Funding Round
February 12, 2026
 · 
5 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial
February 11, 2026
 · 
4 min read
Press Releases
Genprex Announces IP Australia’s Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
February 10, 2026
 · 
8 min read
Press Releases
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
February 8, 2026
 · 
4 min read
Press Releases
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
February 5, 2026
 · 
5 min read
Press Releases
Providence Therapeutics Announces Appointment of Leah Goodman to the Board of Directors
February 5, 2026
 · 
2 min read
Press Releases
Telix Full Year Results 2025 Investor Webcast Notification
February 4, 2026
 · 
5 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
 · 
2 min read
Press Releases
Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial
February 2, 2026
 · 
6 min read
Press Releases
AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic for a Gastrointestinal Cancer with Significant Medical Need
February 2, 2026
 · 
3 min read
Press Releases
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
February 2, 2026
 · 
4 min read
Press Releases
Amplia Therapeutics - Quarterly Activities and Cash Flow Reports - December 2025
February 1, 2026
 · 
7 min read
Press Releases
Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)
February 1, 2026
 · 
11 min read
Load More